Publication | Open Access
Role of Consolidation Durvalumab in Patients With EGFR- and HER2-Mutant Unresectable Stage III NSCLC
57
Citations
14
References
2021
Year
Consolidation DurvalumabMedicinePathologyCancer TreatmentCancer GeneticsOncologyCell BiologyNovel TherapyMolecular Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1